TGFB1 and polyostotic fibrous dysplasia: Anti-fibrotic activity of PFD is well documented and demonstrated from results obtained in animal models and clinical trials of liver damage, however, in these previous publication TGF-β1 expression occurred up to 8 weeks after the induced damage, and no carcinogenic lesions development was reported in these studies.